Novel Antibacterial Fluoride-releasing Dental Materials
新型抗菌释氟牙科材料
基本信息
- 批准号:8197641
- 负责人:
- 金额:$ 34.79万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-03-01 至 2014-01-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAdhesivesAdoptedAnimalsAnti-Bacterial AgentsAreaBacteriaCaries preventionChildClinical TrialsComplexCompomersDentalDental BondingDental EnamelDental MaterialsDental cariesDentistsDevelopmentDiabetes MellitusDrug FormulationsEconomicsElderlyExtravasationFillerFluoridesFrightFutureGenerationsGlassGoalsGrowthHead and neck structureHealthcareHumanIn VitroInvestigationLactic acidLactobacillus caseiLeadLesionLongevityLysineMechanicsMicrobial BiofilmsModelingOral healthPatientsPharmaceutical PreparationsPhysically ChallengedPlant ResinsPopulationPropertyQuality of lifeRecurrenceRiskSeriesSjogren&aposs SyndromeStreptococcus mutansStructureSucroseSystemTestingTooth structureVulnerable PopulationsXerostomiaZirconiumabstractingammonium fluorideantimicrobialbasebiomaterial compatibilitycalcium phosphatediabetichigh riskimprovedirradiationmicroleakagemonomernovelpandemic diseasepreventremineralizationrestorationrestorative materialscale upsealsocioeconomicszirconium oxide
项目摘要
Project Description/Abstract
We propose to investigate and develop novel dental materials that are antibacterial and/or fluoride-
releasing and act synergistically to form a highly effective caries-inhibition restorative
system. Such materials are expected to have an enormous impact on the oral health of the most
vulnerable, high caries-risk, portion of the population: the medically-compromised who suffer from
xerostomia or dry mouth (due to Sj¿gren's syndrome, diabetes, head and neck irradiation, and
medications), children, the elderly, and low socio-economic groups. Dental caries continues to be a
worldwide pandemic disease. While resin-based dental composites (RBC) are widely used to restore
carious teeth, secondary (recurrent) caries remains the leading cause cited for their replacement. Thus,
much effort has been directed towards development of composites that release caries-preventing agents
such as fluoride. Nevertheless, current dental composites are deficient in both fluoride-release and fluoride-
recharge capabilities, and very few have antimicrobial or other capabilities for preventing plaque.
Furthermore, all dental composites and compomers require bonding agents in order to reduce marginal
leakage and limit secondary caries. Yet, both non-fluoride-releasing and low-fluoride-releasing bonding
agents are inherently barriers to the transport of fluoride to caries-prone areas. Another problem is that the
majority of self-etching dental bonding agents are susceptible to hydrolytical degradation, which leads to
eventual leakage, secondary caries and reduced RBC lifetime. On the primary caries prevention front,
sealants, including fluoride-releasing sealants, have shown caries-prevention efficacy, yet the dental
profession has been slow to adopt sealants due, in part, to the fear that caries will continue to progress
under sealed pits and fissures.
The goal of this project is to develop novel monomers with enhanced antibacterial activity, enhanced
fluoride release and recharge, and other capabilities, and combine them with fluoride-releasing fillers and
bioactive fillers to overcome the multiple problems associated with current composites, adhesives and
sealants that limit their caries-inhibition efficacy and restoration longevity. This project has four specific
aims: (1) to formulate and optimize a novel antibacterial fluoride releasing dental composite, (2) to formulate and
optimize a novel hydrolytically stable fluoride-releasing dental bonding agent, (3) to formulate and characterize a
novel antibacterial bioactive sealant that releases calcium, phosphate, and fluoride, (4) to test the overall
caries-inhibition efficacy of the novel anticariogenic dental material system by artificial caries models. The
hypotheses are: (1) Dental materials containing the new fluoride exchange monomers will have enhanced
fluoride release and recharge capabilities while maintaining adequate or improved physical and mechanical
properties. (2) The combination of antimicrobial activity with enhanced remineralization capability will
synergistically lead to significantly higher caries-inhibiting efficacy of the restorative materials. (3) The
combined use of an antibacterial fluoride-releasing composite, bonding agent and bioactive sealant will
further reduce caries.
项目描述/摘要
我们建议研究和开发抗菌和/或氟化物的新型牙科材料
释放并协同行动以形成高效的龋齿抑制修复
系统。预计此类材料将对最大的口腔健康产生巨大影响
脆弱的,高性风险的人口中的一部分:受到医学上的强大症,遭受的痛苦
静脉或口干(由于SJ®Gren的综合征,糖尿病,头颈部和颈部辐照,以及
药物),儿童,老年人和低社会经济群体。牙科车仍然是
全球大流行病。而基于树脂的牙科复合材料(RBC)被广泛用于还原
心牙,次要(经常性)汽车仍然是替换的主要原因。那,
已经大力致力于开发释放汽车预防代理商的公司
例如氟化物。然而,当前的牙科复合材料在氟化物释放和氟化物中都缺乏
充电能力,很少有抗菌或其他防止牙菌斑的能力。
此外,所有牙科组成和兼容者都需要粘结剂才能减少边际
泄漏并限制二级汽车。然而,非氟化物释放和低氟化物释放键
代理本质上是氟化物运输到容易产生区域的障碍。另一个问题是
大多数自我蚀刻牙齿键合剂都容易受到水解降解的影响,这导致
最终泄漏,次要汽车和RBC寿命减少。在预防主要汽车方面,
密封剂,包括释放氟化物的密封剂,已显示出预防效率,但牙科
专业的采用密封剂的速度很慢,部分原因是担心汽车会继续前进
密封的凹坑和裂缝。
该项目的目的是开发具有增强抗菌活性的新型单体,增强
氟化物释放和充电以及其他功能,并将其与氟化物释放的填充剂和
生物活性填充剂以克服与当前复合材料,粘合剂和
限制其抑制汽车效率和恢复寿命的密封剂。这个项目有四个特定的
目的:(1)制定和优化一种新型的抗菌氟化物释放牙科复合材料,(2)以制定和
优化一种新型的水解稳定氟化物释放牙齿粘合剂,(3)以制定和表征
释放钙,磷酸盐和氟化物的新型抗菌生物活性密封剂,(4)测试总体
通过人造性龋模型,新型抗虫生成牙科材料系统的龋齿抑制效率。
假设是:(1)包含新的氟化物交换单体的牙科材料将增强
氟化物释放和充电功能,同时保持足够或改善的物理和机械功能
特性。 (2)抗菌活性与增强的提高能力的结合将
协同导致抑制恢复材料的效率明显更高的汽车。 (3)
抗菌氟化物释放复合材料,粘合剂和生物活性密封剂的联合使用将
进一步减少龋齿。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Formulation and characterization of antibacterial fluoride-releasing sealants.
抗菌释氟密封剂的配方和表征。
- DOI:
- 发表时间:2013
- 期刊:
- 影响因子:1.6
- 作者:Fan,Yuwei;Townsend,Janice;Wang,Yapin;Lee,EunChee;Evans,Katie;Hender,Erica;Hagan,JosephL;Xu,Xiaoming
- 通讯作者:Xu,Xiaoming
Synthesis and Characterization of New Antibacterial Fluoride-Releasing Monomer and Dental Composite.
- DOI:10.1021/mz300579y
- 发表时间:2012-12-27
- 期刊:
- 影响因子:7.015
- 作者:Wang Y;Samoei GK;Lallier TE;Xu X
- 通讯作者:Xu X
Fabrication and Characterization of a Glucose-sensitive Antibacterial Chitosan-Polyethylene Oxide Hydrogel.
葡萄糖敏感抗菌壳聚糖-聚环氧乙烷水凝胶的制备和表征
- DOI:10.1016/j.polymer.2015.11.016
- 发表时间:2016-01-15
- 期刊:
- 影响因子:4.6
- 作者:Xiao Y;Gong T;Jiang Y;Wang Y;Wen ZT;Zhou S;Bao C;Xu X
- 通讯作者:Xu X
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
XIAOMING XU其他文献
XIAOMING XU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('XIAOMING XU', 18)}}的其他基金
High Performance Antimicrobial Fluoride Releasing Dental Materials
高性能抗菌释氟牙科材料
- 批准号:
9904114 - 财政年份:2017
- 资助金额:
$ 34.79万 - 项目类别:
High Performance Antimicrobial Fluoride Releasing Dental Materials
高性能抗菌释氟牙科材料
- 批准号:
9471812 - 财政年份:2017
- 资助金额:
$ 34.79万 - 项目类别:
High Performance Antimicrobial Fluoride Releasing Dental Materials
高性能抗菌释氟牙科材料
- 批准号:
9289696 - 财政年份:2017
- 资助金额:
$ 34.79万 - 项目类别:
Novel Antibacterial Fluoride-releasing Dental Materials
新型抗菌释氟牙科材料
- 批准号:
8013608 - 财政年份:2009
- 资助金额:
$ 34.79万 - 项目类别:
Novel Antibacterial Fluoride-releasing Dental Materials
新型抗菌释氟牙科材料
- 批准号:
7653431 - 财政年份:2009
- 资助金额:
$ 34.79万 - 项目类别:
Novel Antibacterial Fluoride-releasing Dental Materials
新型抗菌释氟牙科材料
- 批准号:
7778363 - 财政年份:2009
- 资助金额:
$ 34.79万 - 项目类别:
LSU DENTAL COBRE: DEVELOPMENT OF NEW ADHESIVE FLOURIDE-RELEASING MONOMERS
LSU Dental COBRE:新型粘合剂氟化物释放单体的开发
- 批准号:
7720559 - 财政年份:2008
- 资助金额:
$ 34.79万 - 项目类别:
Novel F-releasing Nanocomposite Reinforced by Zirconia Nanofibers
氧化锆纳米纤维增强的新型释氟纳米复合材料
- 批准号:
7277582 - 财政年份:2007
- 资助金额:
$ 34.79万 - 项目类别:
Novel F-releasing Nanocomposite Reinforced by Zirconia Nanofibers
氧化锆纳米纤维增强的新型释氟纳米复合材料
- 批准号:
7373646 - 财政年份:2007
- 资助金额:
$ 34.79万 - 项目类别:
Novel F-releasing Nanocomposite Reinforced by Zirconia Nanofibers
氧化锆纳米纤维增强的新型释氟纳米复合材料
- 批准号:
7603100 - 财政年份:2007
- 资助金额:
$ 34.79万 - 项目类别:
相似国自然基金
基于短肽诱导蚕丝蛋白组装的可控粘附生物粘合剂的制备及粘附性能研究
- 批准号:52303272
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
氮杂环丙烷基聚多硫化物可逆粘合剂的分子设计与制备
- 批准号:22378080
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
多酚功能化壳聚糖基组织粘合剂构建及其能量耗散机制探究
- 批准号:82302389
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
负载MUR仿生脂质体粘合剂靶向调控荷菌巨噬细胞IFI204/ARMCX3/Caspase-11焦亡抑制创伤性骨髓炎发生的机制研究
- 批准号:82372421
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
多尺度低表面能粘合剂的构筑及织物基传感器稳定性提升机制研究
- 批准号:22302110
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
相似海外基金
Multiscale Modeling of Sickle Cell Anemia: Methods and Validation
镰状细胞性贫血的多尺度建模:方法和验证
- 批准号:
8723271 - 财政年份:2013
- 资助金额:
$ 34.79万 - 项目类别:
Bridging multiple scales in modeling targeted drug nanocarrier delivery
在靶向药物纳米载体输送建模中桥接多个尺度
- 批准号:
8554530 - 财政年份:2013
- 资助金额:
$ 34.79万 - 项目类别:
Bridging multiple scales in modeling targeted drug nanocarrier delivery
在靶向药物纳米载体输送建模中桥接多个尺度
- 批准号:
8723200 - 财政年份:2013
- 资助金额:
$ 34.79万 - 项目类别:
Multiscale Modeling of Sickle Cell Anemia: Methods and Validation
镰状细胞性贫血的多尺度建模:方法和验证
- 批准号:
8476359 - 财政年份:2013
- 资助金额:
$ 34.79万 - 项目类别:
Novel Antibacterial Fluoride-releasing Dental Materials
新型抗菌释氟牙科材料
- 批准号:
8013608 - 财政年份:2009
- 资助金额:
$ 34.79万 - 项目类别: